“Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia” (2026) Mediterranean Journal of Hematology and Infectious Diseases, 18(1), p. e2026069. doi:10.4084/MJHID.2026.069.